does tirzepatide reduce muscle mass vs. Semaglutide: Which GLP-1 Better Preserves Muscle? [SURMOUNT-5 Data] Combat Muscle Loss on Semaglutide

However, mechanistic plausibility does not establish clinical benefit, and the current evidence base does not support claims of improved healing, accelerated recovery, or reduced complication rates following orthopaedic surgery

Understanding Semaglutide Semaglutide, originally developed as a medication for managing type 2 diabetes, belongs to a class of drugs known as GLP-1 receptor agonists

Claims-based data from FairHealth found the number of adults prescribed a GLP-1 drug increased from 0.9% in 2019 to 4% in 2024, and the number of adults with overweight, obesity or diabetes prescribed the medications increased from 0.3% in 2019 to 2.05% in 2024

Semaglutide injection is a glucagon-like peptide-1 (GLP-1) receptor agonist that affects hunger signals in your brain almost immediatelyyet most patients see noticeable weight loss results between weeks 4 and 12 of consistent therapy